CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법
본원에 기재된 발명은 골수형성이상 증후군 (MDS)을 치료하기 위해 아자시티딘 및 CYP3A 억제제와 병용한 베네토클락스를 투여함을 포함하는 치료학적 투약 용법에 관한 것이다. The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (M...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHA JIUHONG KYE STEVE H HAYSLIP JOHN SALEM AHMED |
| description | 본원에 기재된 발명은 골수형성이상 증후군 (MDS)을 치료하기 위해 아자시티딘 및 CYP3A 억제제와 병용한 베네토클락스를 투여함을 포함하는 치료학적 투약 용법에 관한 것이다.
The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240006660A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240006660A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240006660A3</originalsourceid><addsrcrecordid>eNrjZOh3jgwwdlR4M23rmwVzgEjh9YZ-hTdTW97Mm_Cme87b7g2vp8x4tXmPwuvNE9_MWvl26hyFV5tXvOmY8XbG1DctG9_M3fKmuVHhzbK5b2e3vNq64c3cGQpvds54vbgHqFnhTdMasJ4Zr3ZsUHgzpwWk-_WmBa9blrxtW_C2ccvruXvfdC1ReNux5s3UvQpApa83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRiYGBgZmZmYGjsbEqQIARdN3bg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법</title><source>esp@cenet</source><creator>ZHA JIUHONG ; KYE STEVE H ; HAYSLIP JOHN ; SALEM AHMED</creator><creatorcontrib>ZHA JIUHONG ; KYE STEVE H ; HAYSLIP JOHN ; SALEM AHMED</creatorcontrib><description>본원에 기재된 발명은 골수형성이상 증후군 (MDS)을 치료하기 위해 아자시티딘 및 CYP3A 억제제와 병용한 베네토클락스를 투여함을 포함하는 치료학적 투약 용법에 관한 것이다.
The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS).</description><language>kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240115&DB=EPODOC&CC=KR&NR=20240006660A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240115&DB=EPODOC&CC=KR&NR=20240006660A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHA JIUHONG</creatorcontrib><creatorcontrib>KYE STEVE H</creatorcontrib><creatorcontrib>HAYSLIP JOHN</creatorcontrib><creatorcontrib>SALEM AHMED</creatorcontrib><title>CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법</title><description>본원에 기재된 발명은 골수형성이상 증후군 (MDS)을 치료하기 위해 아자시티딘 및 CYP3A 억제제와 병용한 베네토클락스를 투여함을 포함하는 치료학적 투약 용법에 관한 것이다.
The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOh3jgwwdlR4M23rmwVzgEjh9YZ-hTdTW97Mm_Cme87b7g2vp8x4tXmPwuvNE9_MWvl26hyFV5tXvOmY8XbG1DctG9_M3fKmuVHhzbK5b2e3vNq64c3cGQpvds54vbgHqFnhTdMasJ4Zr3ZsUHgzpwWk-_WmBa9blrxtW_C2ccvruXvfdC1ReNux5s3UvQpApa83TeVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGRiYGBgZmZmYGjsbEqQIARdN3bg</recordid><startdate>20240115</startdate><enddate>20240115</enddate><creator>ZHA JIUHONG</creator><creator>KYE STEVE H</creator><creator>HAYSLIP JOHN</creator><creator>SALEM AHMED</creator><scope>EVB</scope></search><sort><creationdate>20240115</creationdate><title>CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법</title><author>ZHA JIUHONG ; KYE STEVE H ; HAYSLIP JOHN ; SALEM AHMED</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240006660A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHA JIUHONG</creatorcontrib><creatorcontrib>KYE STEVE H</creatorcontrib><creatorcontrib>HAYSLIP JOHN</creatorcontrib><creatorcontrib>SALEM AHMED</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHA JIUHONG</au><au>KYE STEVE H</au><au>HAYSLIP JOHN</au><au>SALEM AHMED</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법</title><date>2024-01-15</date><risdate>2024</risdate><abstract>본원에 기재된 발명은 골수형성이상 증후군 (MDS)을 치료하기 위해 아자시티딘 및 CYP3A 억제제와 병용한 베네토클락스를 투여함을 포함하는 치료학적 투약 용법에 관한 것이다.
The invention described herein relates to therapeutic dosing regimens comprising administering venetoclax in combination with azacitidine and a CYP3A inhibitor for treating myelodysplastic syndromes (MDS).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20240006660A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CYP3A 억제제 및 아자시티딘과 병용한 골수형성이상 증후군의 치료시 사용하기 위한 베네토클락스 투약 용법 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A55%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHA%20JIUHONG&rft.date=2024-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240006660A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |